Definition of
Thrombocytopenia
• Plateletcount <150,000/μL
• Often found incidentally or during bleeding/bruising work-
up
• Immune-mediated processes are the most common causes
in children
4.
ITP
• Most commoncause of isolated thrombocytopenia in
children
• Peak age: 2–5 years
• Sudden bruising, petechiae, or mucosal bleeding
• Often post-viral or post-vaccine, but many cases idiopathic
• Primary ITP: No associated systemic disease
• Secondary ITP: Associated with SLE, HIV, CVID, ALPS, drugs
• By Duration:
• Newly diagnosed: <3 months
• Persistent: 3–12 months
• Chronic: >12 months
6.
Pathogenesis
• Autoantibodies (IgG)against GP IIb/IIIa, Ib/IX, etc.
• Antibody-coated platelets macrophage clearance (mainly
→
spleen)
• Antibodies may also impair megakaryocyte function
• Involvement of T-cell cytotoxicity and immune
dysregulation (Tregs/B-cells)
7.
Epidemiology
• Annual incidence:1–6.4/100,000 children
• Underdiagnosed due to asymptomatic or mild cases
• Peak: 2–5 years, minor secondary peak in adolescence
8.
Clinical Presentation
• Healthy-appearingchild with:
• Sudden petechiae, purpura, bruising
• ± mucosal bleeding (epistaxis, oral, GU, GI)
• Often preceded by viral illness or MMR vaccination
• Systemic signs absent (no fever, bone pain, hepatosplenomegaly)
10.
Bleeding Severity
• Mosthave mild mucocutaneous bleeding
• 40% have mucosal bleeding
• Serious bleeding: ~3%
• Intracranial hemorrhage (ICH): <1%
• High risk if platelets <10,000/μL
11.
Diagnostic
evaluation
• CBC withdifferential
• Peripheral blood smear
• Reticulocyte count
• Direct antiglobulin test
• Immunoglobulin levels
Further tests if atypical findings
12.
Diagnostic Criteria
• Platelets<100,000/μL
• Normal CBC, normal smear
• No systemic symptoms
• Diagnosis of exclusion
Note: Antiplatelet antibody testing not helpful (low
sensitivity/specificity)
Management
• Observation formild/no bleeding
• Treat if:
• Platelets <10,000/μL
• Mucosal or life-threatening bleeding
• First-line: IVIG, anti-D (if Rh+), or steroids
• Reserve platelet transfusions for emergencies
16.
Severe Bleeding
Management
• Platelettransfusions: 10–30 mL/kg bolus
• IVIG + Steroids ± anti-D
• Add TPO-RA (romiplostim) to sustain counts
• Consider ICU admission for ICH or GI hemorrhage
18.
Disease Course
• 80–90%recover in 3–6 months
• 10–20% chronic ITP (>12 months)
→
• Risk factors for chronicity:
• Older age
• No preceding infection
• Less severe thrombocytopenia at diagnosis
• Insidious onset
19.
Chronic ITP:
Management
• Avoidcontact sports, NSAIDs
• Monitor labs and menstrual bleeding
• First-line: IVIG, steroids
• If recurrent/severe:
• TPO-RAs preferred
• Rituximab if autoimmune-associated
• Splenectomy rare (reserved, due to lifelong risks)
20.
Prognosis
• 30% spontaneousremission by 2 years
• 50% remission by 5 years
• Severe bleeding <10% over 5 years
• Younger age = better prognosis
Approach to PediatricBleeding
● Begin with a focused history
● Follow with targeted physical exam
● Order baseline labs based on findings
● Use structured tools like bleeding assessment scores
23.
Focused History
● Onsetand frequency of bleeding
● Triggering events (trauma, surgery, dental work)
● Type of bleeding: mucosal vs deep tissue
● Past medical history, meds, supplements
● Family history of bleeding disorders
● Possible child abuse in unexplained bruising
24.
Bleeding Assessment Tools
●ISTH Bleeding Assessment Tool (BAT)
○ Score 3 further evaluation needed
≥ →
● Helps quantify symptoms and guide testing
● Use when the history is unclear or symptoms vague
26.
Child Abuse Considerations
●Pattern and location of bruises inconsistent with history
● Multiple stages of healing
● Delay in seeking care
● Consider abuse in any atypical bruising without coagulopathy
27.
Initial Lab Work-Up
●CBC + Platelet count
● Peripheral smear
● Prothrombin time (PT)
● Activated partial thromboplastin time (aPTT)
● Fibrinogen
● Von Willebrand panel:
○ VWF antigen
○ VWF activity
○ Factor VIII level
28.
Diagnostic Approach
● Useinitial lab results to narrow causes
● Algorithm-based evaluation is recommended
● Examples:
○ ↓ Platelets: consider ITP, leukemia, DIC
○ Normal platelets + PT/aPTT: consider factor
↑
deficiencies
○ Normal PT/aPTT + mucosal bleeding: think VWD
Definition
● Injury inflictedupon a child by a caregiver or parent
● Legal and cultural definitions may vary
● Key: Inflicted, not accidental trauma
33.
Epidemiology
● Thousands ofinjuries and deaths annually worldwide
● High risk of repeated harm if not intervened
● Early recognition = lifesaving
● Most common in children under 5 years
34.
Approach to SuspectedAbuse
● Keep abuse in differential diagnosis of any unexplained
injury
● Carefully assess:
○ History: inconsistency, delay in care
○ Physical exam: patterned injuries, fractures
● Involve child protection teams when possible
● Report any suspicion to child services
35.
Risk Factors
(Contextual, NotDiagnostic)
● Young age
● Household history of abuse
● Family stress, poverty, isolation
● Caregiver mental illness or substance use
● Race or socioeconomic status should NOT be used to guide
suspicion
36.
Red Flag Historyfor Abuse
● Injury inconsistent with developmental stage
● Vague or changing history
● Delay in seeking medical attention
● Recurrent injuries with no clear cause
● Explanation not matching injury severity
Red Flag PhysicalExam Findings
● Bruises in non-mobile infants
● Patterned or clustered bruises
● Burns (e.g., immersion, cigarette)
● Retinal hemorrhages
● Multiple fractures in various healing stages
● Genital or perianal injuries
41.
When to PursueFull Work-Up
● Presence of any red flag history or exam finding
● Use institutional abuse protocol (lab + imaging)
● Refer to child protection team or abuse specialist
● Transfer if specialized services are not available
42.
Screening
Recommendations
• ED/urgent care:Routine screening for <5 years recommended
• Increases detection
• Reduces missed cases
• Use validated tools
• Requires institutional commitment and team collaboration
43.
Primary Care
Limitations
• Universalscreening not yet supported by evidence
• Rely on clinical vigilance + family dynamics assessment
• Incorporate abuse awareness into developmental visits